PROGRAM

EXHIBIT HALL ACTIVITIES
Industry Expert Theaters (continued)
3:10 PM – 3:40 PM
Exhibit Hall
Furosemide 2.0: A Convenient Alternative
to Intravenous Furosemide Treatment
Faculty:
Pieter Muntedam, MD
Description:
scPharmaceuticals is developing furosemide for subcutaneous
delivery by means of a patch pump. In order to be given
subcutaneously, a buffered formulation was developed with
a neutral pH ( 7 . 4 as compared to commercial furosemide
which is alkaline with a pH of around 9 . 0 ). The company is
developing a patch pump for convenient administration of
80
mg. This wold provide "iv-like" diuresis without the need
for iv. Theere are several intended uses: In the pre-acute
patients who do need more than oral alone can provide; in
the post-acute patient to reduce length of stay and; avoidance
of need for iv placement. It is not indicated for use in
emergency situations.
Sponsored by scPharmaceuticals
5:15 PM – 6:15 PM
Exhibit Hall
A New Treatment Approach for Patients
With Chronic Systolic Heart Failure
Faculty:
Sheryl Chow, PharmD
Sponsored by Amgen
Monday, September 28
8:30 AM – 9:30 AM
Exhibit Hall
A New Treatment Approach for Patients
With Chronic Systolic Heart Failure
Faculty:
Vasilios Papademetriou, MD
10:10 AM – 10:40 AM
Exhibit Hall
Navigating Patient Conversations: Tough
Choices with Advanced Heart Failure
Therapies
Faculty:
Larry Allen, MD, MHS – University of Colorado
Sean Pinney, MD – Mount Sinai Medical Center
Description:
Learn how to address the most challenging patient conversations
when speaking with advanced heart failure patients
about LVAD therapy. Discuss case studies highlighting
best practices and techniques to help the conversation be as
effective as possible.
Sponsored by Thoratec Corporation
12:10 PM – 1:10 PM
Exhibit Hall
New Heart Failure Treatment Approved:
Highlights of Prescribing Information
Faculty:
Javed Butler, MD - Stony Brook University
Barry Greenberg, MD - University of California, San Diego
Description:
Join Dr. Javed Butler and Dr. Barry Greenberg as they
present information on a new heart failure medication at
the Novartis Product Theater. Presentation topics will cover
indication and usage, dosage and administration, dosage
forms and strengths, warnings and precautions, adverse
reactions, clinical pharmacology, mechanism of action,
clinical studies, and how supplied/storage and handling.
This presentation provides a thorough review of the clinical
profile for this new heart failure medication.
Sponsored by Novartis Pharmaceuticals Corporation
Sponsored by Amgen
101